Dsuvia™ (sufentanil) – New drug approval
November 2, 2018 - AcelRx announced the FDA approval of Dsuvia (sufentanil) for use in adults in a certified medically supervised healthcare setting, such as hospitals, surgical centers, and emergency departments, for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Top